VYNE Therapeutics Overview
VYNE Therapeutics Discounted Cash Flow
DCF Analysis for VYNE.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.48
Current Fair Value
$0.48
↓ 23.3% Downside
Overvalued by 23.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison